Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Receives $21.80 Consensus Price Target from Analysts

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) has been assigned an average rating of “Moderate Buy” from the ten analysts that are presently covering the company, Marketbeat Ratings reports. Five analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $21.90.

SBRA has been the topic of several analyst reports. Wells Fargo & Company raised their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an “overweight” rating in a report on Tuesday, November 25th. Wall Street Zen cut shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a report on Friday, January 23rd. Citigroup boosted their price target on shares of Sabra Healthcare REIT from $21.00 to $24.00 and gave the stock a “buy” rating in a report on Wednesday, February 18th. Citizens Jmp increased their price objective on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a research report on Wednesday, February 18th. Finally, Truist Financial raised their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a report on Friday.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in SBRA. Rothschild Investment LLC lifted its stake in Sabra Healthcare REIT by 164.6% during the fourth quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock worth $27,000 after purchasing an additional 889 shares during the last quarter. Smartleaf Asset Management LLC increased its stake in Sabra Healthcare REIT by 97.7% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 714 shares during the last quarter. Founders Capital Management acquired a new stake in Sabra Healthcare REIT during the third quarter worth approximately $28,000. Strengthening Families & Communities LLC acquired a new stake in Sabra Healthcare REIT during the fourth quarter worth approximately $29,000. Finally, Danske Bank A S purchased a new stake in shares of Sabra Healthcare REIT during the 3rd quarter worth approximately $30,000. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Trading Down 0.8%

SBRA opened at $20.62 on Monday. The business has a fifty day moving average price of $19.65 and a 200 day moving average price of $19.01. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.29 and a quick ratio of 4.29. Sabra Healthcare REIT has a 12 month low of $15.75 and a 12 month high of $21.07. The stock has a market capitalization of $5.20 billion, a price-to-earnings ratio of 32.22, a PEG ratio of 1.67 and a beta of 0.64.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.26). The company had revenue of $201.35 million during the quarter, compared to analyst estimates of $201.97 million. Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. Sabra Healthcare REIT’s revenue for the quarter was up 16.2% on a year-over-year basis. During the same period in the prior year, the business earned $0.36 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Sell-side analysts expect that Sabra Healthcare REIT will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, February 27th. Shareholders of record on Friday, February 13th were paid a $0.30 dividend. The ex-dividend date was Friday, February 13th. This represents a $1.20 dividend on an annualized basis and a yield of 5.8%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 187.50%.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.